SG Americas Securities »

Terns Pharmaceuticals shares owned by SG Americas Securities

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2024-12-31 $185k 33k 5.55
2024-09-30 $199k 24k 8.36

More positions owned by SG Americas Securities

Apple (AAPL)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Palo Alto Networks (PANW)
UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Royal Caribbean Cruises (RCL)
Invesco Qqq Trust Series 1 (QQQ)
Tesla Opt Call Option
Spdr S&p 500 Etf (SPY)
SPDR Gold Trust (GLD)
MasterCard Incorporated (MA)
SPDR S&P MidCap 400 ETF (MDY)

View all positions for SG Americas Securities

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Vivo Capital
BlackRock
Deep Track Capital
Schonfeld Strategic Advisors
Vanguard Group
Citadel Advisors
Morgan Stanley
Nuveen Asset Management
Candriam Luxembourg S.C.A.
Driehaus Capital Management
Millennium Management
Geode Capital Management
T. Rowe Price Associates

View all funds holding Terns Pharmaceuticals